Aastrom Set To Start Pivotal Work On Stem Cell Therapy May 9, 2007 By Aaron Lorenzo Aastrom Biosciences Inc. received FDA clearance to begin a pivotal trial of its regenerative stem cell product in osteonecrosis of the femoral head. (BioWorld Today)Read More
RSS